There are better buys than Pfizer
Christopher Norwood • November 18, 2020

There are better buys than Pfizer.

Clients are asking if we should buy Pfizer

Pfizer announced that its vaccine candidate was found to be more than 90% effective. The test population were participants without evidence of prior SARS-CoV-2 infection. The announcement caused the S&P 500 to open 3.8% higher Monday morning. PFE rose around 15% at the open before closing Monday with a gain of 7.7%. PFE has 5.5 billion shares outstanding. The stock rose 2.80 on Monday, adding $15.5 billion to Pfizer’s market cap. The vaccine is in phase-3 of its drug trial. A high percentage of vaccines fail in either phase-3 or phase-4. Even if it does make it to market, the vaccine is unlikely to generate sufficient cash flow to warrant the increase in market cap. Competition from other vaccines is certain. There are two more vaccines in trials that are promising and could still beat Pfizer to market.


I received a text Monday morning from a client asking if we should buy Pfizer. A second text from a different client soon followed. They both felt that PFE might be worth owning given the positive vaccine news. I texted back that I would look at PFE. I did not agree to look because of the vaccine news. It was already priced into the stock (and then some). An investor buying a stock should only do so if they expect to earn an above market, risk-adjusted return. Otherwise buy the market, which is your default equity investment. News that causes a stock to jump only adds additional return if you buy the stock before it jumps. Once the price has adjusted to the news, there is no reason to buy because there is no excess return left to capture. The stock has already priced it in.



I did look at PFE as a possible buy. It did not pass our valuation process or meet our requirements for ownership. We do not look at one stock in isolation. In this case, we looked at a few other pharmaceutical companies as well. It turns out that we might buy a pharmaceutical company in the next few months. It just won’t be Pfizer.


Regards, 

Christopher R Norwood, CFA

Chief Market Strategist

Diversification Critical in the Coming Decade

By Christopher Norwood • July 7, 2025
Executive Summary The S&P 500 rose 1.7% in a holiday-shortened week, finishing at 6,284.65 Volatility continues to fall from its elevated levels in early April The S&P is up 6.76% year-to-date. Industrials are leading the way, up 13.40% Price determines returns when buying an asset  Diversify away from a concentrated U.S. large-cap stock portfolio Job growth has been holding steady for almost a year now Analysts have been raising earnings estimates recently 90-day tariff suspension ends on Wednesday The Stock Market The S&P 500 rose 1.7% in a holiday-shortened week. The Nasdaq rose 1.6%. Both indexes set new record highs with the S&P reaching 6,284.65 on Thursday afternoon. The jobs report out Thursday spurred the S&P higher. The index gapped up at the open, closing Thursday up 0.83% (see chart below). The S&P 500 is up 26% from the selloff low on April 8, while the Nasdaq has surged 34.9%.

The Fear Gauge has Fallen

By Christopher Norwood • June 30, 2025
Executive Summary The S&P 500 rose 3.4% last week, climbing to 6,173.07 The Magnificent 7 are outperforming the S&P 493 by over 18% since April The Cboe Volatility Index (VIX) fell as low as 16.11 last week Investors seem unconcerned about tariffs and war Treasury interest rates are starting to fall The Fed has little reason to cut if unemployment isn't moving higher The stock market is at record highs Corporate bond spreads are tight, meaning credit is abundant The dollar has fallen by around 10% in 2025 Inflation is expected to move higher because of tariff The Stock Market The S&P 500 rose 3.4% last week. The Israeli-Iranian ceasefire was credited with the surge to the upside. The index had lost 0.7% over the prior two weeks.

The Federal Reserve sees slower economic growth and higher inflation

By Christopher Norwood • June 23, 2025
Executive Summary The S&P 500 gained 0.3% last week, climbing to 5,967.84 The index is having trouble staying above 6,000 Technical indicators are turning somewhat negative The Federal Reserve kept the overnight rate at 4.25% - 4.50% The updated “dot plot” shows a divided Fed Seven members indicate no rate cuts in 2025 Eight members forecast two rate cuts in 2025 The Fed is forecasting a slower economy in 2025 and 2026 The hard data is starting to point to a slowing economy Inflation is still well above the Fed’s 2% target

War in the Middle East

By Christopher Norwood • June 16, 2025
Executive Summary The S&P 500 fell 0.4% last week to finish at 5,976.97 Friday's sell-off due to Israel's attack on Iran The Volatility Index (VIX) is rising due to the war in the Middle East Higher volatility is usually associated with a down move in the market There is no chance of a Fed Funds Rate cut at this week’s meeting according to the CME FedWatch Tool The unemployment rate has been rising slowly The dollar continues to weaken The U.S. needs to reduce its spending to avoid a currency crisis  The Stock Market

A Slowing Economy and Higher Inflation

By Christopher Norwood • June 9, 2025
Executive Summary The S&P 500 rose 1.5% last week to finish at 6,000.36 The May payroll number came in above estimates The U.S. economy is slowing, despite the S&P 500 poking above 6,000 The Labor Force Participation Rate fell to 62.4% from 62.6% Inflation may have bottomed and is set to rise The services price paid index is pointing towards a higher CPI The declining dollar is a concern Tariffs are a tax The Q2 nowcast seems to be indicating that negative economic impacts from tariffs won’t affect Q2 International markets have far outperformed U.S. markets so far in 2025 The Stock Market The S&P 500 climbed 1.5% last week and closed at 6,000.36. The Dow rose 1.3% while the Nasdaq rose 2.0%. Interest rates rose as bond prices fell. A stronger-than-expected jobs report on Friday is getting the blame for rising yields. The jobs report was also responsible for the S&P’s gap-up open on Friday (chart below).

High Level of Uncertainty Surrounding Trade Policy

By Christopher Norwood • June 2, 2025
Executive Summary The S&P 500 rose 1.9% last week to finish at 5911.69 The S&P 500 rose 6%, the Dow rose 3.8% and the Nasdaq climbed nearly10% in May Could see another test of support around 5,800 this week Several longer-term negative divergences may be pointing to a tough summer Declining new highs during an advancing market is a negative Earnings estimates for 2025 and 2026 have been trending lower Earnings drive the stock market over the long run

A Trading Range Market Most Likely

By Christopher Norwood • June 2, 2025
Executive Summary The S&P 500 fell 2.6% last week to close at 5,802.82. The 20-Year Treasury auction went poorly. The yield rose above 5%. The 5% threshold has twice this year resulted in the administration adjusting its stance on tariffs. (Make that three times as Trump over the weekend gives the U.K. until July 9 th .) Longer-term inflation expectations are rising. Moody’s downgraded the U.S. to Aa1 on 16 May. The credit default swaps market sees the U.S. as a Baa1/BBB+ credit, on par with Greece. The tax cut bill will add to the deficits and debt. Long-term interest rates might well continue to rise.

Buying Companies on Sale is a Successful Strategy

By Christopher Norwood • May 19, 2025
Executive Summary The S&P 500 rose 5.3% last week to finish at 5,958.38 The Dow advanced 3.4% and the Nasdaq added 7.2% A falling VIX means investor confidence is increasing A 90-day pause in the trade war sent the S&P higher Earnings estimates are falling along with GDP growth forecasts Earnings and interest rates drive the stock market over the long run Investors are chasing performance Small business hiring plans and job openings haven’t improved Norwood Economics continues to look for good companies on sale The Stock Market

Trump Decides to Save Christmas

By Christopher Norwood • May 19, 2025
Executive Summary The S&P 500 fell 0.5%, to finish at 5,659.91 The Dow fell 0.3%, and the Nasdaq dropped 0.5% The 200-day moving average is the next resistance U.S. nominal GDP growth expected to slow significantly Bank of America shifts investment focus Norwood Economics already has exposure to gold for most clients Norwood Economics is overweight international stocks The risk of both higher unemployment and higher inflation has increased The Federal Reserve declined to lower the fed funds rate last week The Stock Market

Remain Diversified. Prepare for higher-than-normal volatility

By Christopher Norwood • May 5, 2025
Executive Summary The S&P 500 rose 2.9% last week to finish at 5,686.67 The Dow was up 3% last week, and the Nasdaq rose 3.4% The counter-trend rally is ongoing Investors are extremely bearish due to worries about the trade war Political prediction markets are back Exploding imports are not a sign of weakening demand The April jobs report was better than expected The Trade War continues Capital is flowing into international and emerging markets The US dollar will likely continue to weaken The Stock Market
More Posts